KUALA LUMPUR: The National Pharmaceutical Regulatory Agency (NPRA) under the Health Ministry has received the clinical data from Pfizer on the Covid-19 vaccine, says Khairy Jamaluddin.
The Science, Technology and Innovations Minister said the decision to use the Pfizer vaccine lies with the NPRA, which would need to register and approve the vaccine, and the Health Ministry.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
